Women who go through natural menopause before age 40 face a 40% higher lifetime risk of coronary heart disease. Black women are three times as likely to experience early menopause as white women.

A great-grandmother has become the first patient in a Kent hospital to undergo a keyhole procedure to treat a potentially ...

Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.

From earlier cholesterol checks to new risk tests, UVA’s Dr. Christopher Kramer explains what the updates mean for your health.

When doctors found out Ainsley Flynn had viral myocarditis, they leaped into action to save her. Now, Flynn is giving back.

A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...

The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...

JenaValve Technology has received premarket approval from the FDA for its Trilogy THV System.  The system is now the first transcatheter device in the U.S. with a dedicated indication for patients ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...